Biotech · Private company · New York, NY, US

Enyx Therapeutics, LLC

Track this companyFree. Adds Enyx Therapeutics, LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency in Post-menopausal East Asian WomenFiscal year 2026 · $791.9KNIH RePORTER 5R42AA028465-03 · fetched Nov 12, 2026
Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency in Post-menopausal East Asian WomenFiscal year 2025 · $1.3MNIH RePORTER 2R42AA028465-02A1 · fetched Nov 12, 2026
Safety of AAV-mediated C1 Esterase Inhibitor Gene Therapy for Hereditary AngioedemaFiscal year 2024 · $275.7KNIH RePORTER 1R41AI181097-01 · fetched Nov 12, 2026
Gene Therapy-mediated Angiogenesis to Enhance Survival of Transplanted FatFiscal year 2024 · $295.9KNIH RePORTER 1R41HL170928-01A1 · fetched Nov 12, 2026